Text Size

Topical Antibiotics and Intravitreous Injections

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2006 by Stanford University.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Stanford University
ClinicalTrials.gov Identifier:
NCT00410891
First received: October 2, 2006
Last updated: December 11, 2006
Last verified: December 2006
History of Changes
  Purpose

Evaluation of efficacy of topical preoperative antibiotics in patients undergoing intravitreous injections.


Condition Intervention Phase
Intravitreous
Injections
 Drug: gatifloxacin
 Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Single Blind

Resource links provided by NLM:

MedlinePlus related topics: Antibiotics
U.S. FDA Resources

Further study details as provided by Stanford University:

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • intravitreous injection

Exclusion Criteria:

  • antibiotic use
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00410891

Contacts
Contact: Christopher Ta, MD 650-725-5743

Locations
United States, California
Stanford Recruiting
Stanford, California, United States, 94304
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Christopher Ta, MD Stanford University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00410891     History of Changes
Other Study ID Numbers: 96803 (eProtocol 4384
Study First Received: October 2, 2006
Last Updated: December 11, 2006
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Gatifloxacin
Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on May 19, 2013